Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al.

Gilbert, J W; Wolpin, B; Clancy, T; Wang, J; Mamon, H; Shinagare, A B; Jagannathan, J; Rosenthal, M

Gilbert, J W; Wolpin, B; Clancy, T; Wang, J; Mamon, H; Shinagare, A B; Jagannathan, J; Rosenthal, M.

Afiliação

Gilbert JW; Department of Imaging, Dana-Farber Cancer Institute, Boston.
Wolpin B; Department of Radiology, Brigham and Women's Hospital, Boston.
Clancy T; Harvard Medical School, Boston.
Wang J; Harvard Medical School, Boston.
Mamon H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston.
Shinagare AB; Harvard Medical School, Boston.
Jagannathan J; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital and Gastrointestinal Surgical Center, Dana-Farber/Brigham and Women's Cancer Center, Boston.
Rosenthal M; Harvard Medical School, Boston.

Ann Oncol ; 28(9): 2316, 2017 09 01.

Article em En | MEDLINE | ID: mdl-28541392

Assuntos

Neoplasias Pancreáticas; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Idioma: En Ano de publicação: 2017 Tipo de documento: Article